Lv51
930 积分 2023-05-29 加入
2182-LB: Development and Characterization of a Humanized GLP-1 Receptor Mouse Model for the Evaluation of Small-Molecule GLP1R Agonists
2天前
求助中
Effects of sclerostin antibodies in animal models of osteoporosis
6天前
已完结
Romosozumab rescues impaired bone mass and strength in a murine model of diabetic kidney disease
6天前
已完结
1676-P: A Novel GLP1R/GCGR Dual Agonist, DA-1726 Elicits Weight Loss Superior to Semaglutide in Diet-Induced Obese Rats
28天前
已关闭
2180-LB: Bimagrumab Augments Metabolic Rate to Improve Incretin-Induced Weight Loss in Obese Mice
28天前
已关闭
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
29天前
已完结
纯种小鼠刀豆素A诱发性肝损害中CD4+T细胞作用的初步研究
1个月前
已关闭
Immune and inflammatory mechanisms in hypertension
1个月前
已完结
C57BL/6J小鼠构建肥胖动物模型评价
1个月前
已完结
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
2个月前
已完结
皖公网安备34019202002308
